Trial Details
COMPLETEDBasic Information
| Clinical ID | c4713 |
|---|---|
| Identifier | NCT00074542 |
| Trial Title | An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Epanova™ (Omega-3 Free Fatty Acids) |
Participant Information
| Sponsor | Tillotts Pharma AG |
|---|---|
| City | Atlanta |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2002-09 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2005-01 |